Results 201 to 210 of about 1,117,895 (256)

A framework to evaluate surrogate endpoints at the trial level: analysis in colorectal cancer. [PDF]

J Natl Cancer Inst
Chia BJ, Allegra C, Krishnamurthi S, Lieu C, Loree JM, Shi Q.   +5 more
europepmc   +1 more source

Survival benefit and toxicity trade-offs of first-line chemoimmunotherapy in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized trials. [PDF]

Front Oncol
Zeng X, Chen J.
europepmc   +1 more source

Immune-related adverse events and clinical outcomes in patients with solid tumors treated with adebrelimab: a real-world exploratory study. [PDF]

Front Oncol
Chao Y, Chang F, Li Q, Cheng X, Wang Y.
europepmc   +1 more source

Setting the standard: empirical benchmarks for case-level site-central discordance in radiographic endpoints in oncology clinical trials. [PDF]

Contemp Clin Trials Commun
Goldmacher GV, Goldberg CM, Boyle L, Jia L, Gause CK, Green MC, Schwartz LH.   +6 more
europepmc   +1 more source